Shedding light on vitreous opacities during cataract surgery

Article

Physicians offer pearls for improving visualisation in eyes using retroillumination techniques.

Reviewed by Dr Joseph W. Fong and Dr Ahmed A. Sallam

A chandelier is directed horizontally toward the lens. (Image courtesy of Dr Josheph W. Fong)

A chandelier is directed horizontally toward the lens. (Image courtesy of Dr Josheph W. Fong)

Cataract surgery can be difficult to perform when dense vitreous opacities are present, due to the absence of the red reflex. Even when cataract surgery is combined with vitrectomy, this difficulty still exists because, in many cases, the view is too poor to permit vitrectomy to clear the vitreous opacities before removal of the cataract.

Dr Joseph Fong and Dr Ahmed A. Sallam, both from the Harvey & Bernice Jones Eye Institute at the University of Arkansas for Medical Sciences in Little Rock, Arkansas, United States, shared their pearls for improving the visualisation in these eyes using retroillumination techniques that include a 25-gauge chandelier or a light pipe.

Retroillumination configurations using the chandelier

The doctors described two configurations using the 25-gauge chandelier. In the first, the chandelier was directed down towards the vitreous. In the case being demonstrated, the patient had a dense vitreous haemorrhage due to diabetic retinopathy. Dr Fong advised that the view can often be improved in this scenario by extinguishing the room and microscope lights and by depending only on the retroillumination provided by the chandelier.

In a second case, Drs Fong and Sallam demonstrated the view achieved when the chandelier was directed horizontally or towards the lens. “Directly illuminating the lens from behind provides the surgeon with crisp and detailed visualisation of the lens structure and is often very helpful in cases where vitreous haemorrhage is very dense,” Dr Fong said.

Retroillumination using a light pipe

Use of the light pipe means that the surgeon has to perform the procedure using one hand.

In another case of a patient with a dense vitreous haemorrhage from diabetic retinopathy, Dr Fong showed how to maximise use of the light pipe. As in the previous case using the chandelier, maximum visualisation was achieved when the lights from the microscope and rooms were turned off.

Dr Fong explained that a light pipe has an advantage compared with a chandelier because an experienced vitreoretinal surgeon has real-time control over the position of the light pipe at all times intraoperatively. However, use of the light pipe means that the surgeon has to perform the procedure using one hand, which is a major disadvantage.

The surgeon does have the option of removing the light pipe to chop the nucleus using both hands. After the chop procedure is completed, the light pipe can be re-inserted to facilitate a better view of the cortex to be removed.

“The chandelier and light pipe are both great options to achieve retroillumination and optimal visualisation during these challenging cataract surgeries,” Dr Fong said. “Using the chandelier has an advantage over the light pipe in that the surgeon can use both hands throughout cataract surgery. This frees the surgeon from concerns about the position of the light source and facilitates his or her concentration on the details of the challenging surgery.”

Another challenging surgical scenario is encountered in cases of active endophthalmitis. Dr Fong demonstrated insertion of a light pipe into a trocar to retroilluminate the lens during the capsulorhexis. The light pipe was then inserted through the limbal side port to illuminate the lens during phacoemulsification.

“These retroillumination techniques can be used to conquer cataract surgery when many different types of vitreous opacities are present,” Dr Fong concluded.

Ahmed A. Sallam, MD, PhD
E: ASallam@uams.edu
This article is adapted from Dr Fong and Dr Sallam’s presentation at the American Academy of Ophthalmology Annual Meeting in New Orleans, Louisiana, US. Drs Fong and Sallam have no financial interests in any aspect of this report.
Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.